दवाओं की अंतःक्रिया
Exenatide injectable + Insulin degludec-liraglutide
गंभीरता: गंभीर
Exenatide injectable and Insulin degludec-liraglutide: major interaction.
अंतिम अपडेट
केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।
इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।
सारांश
Exenatide is a GLP-1 receptor agonist, and the combination product already contains liraglutide, so the two would duplicate therapy. Together they increase gastrointestinal adverse effects and the risk of hypoglycemia without added benefit.
इस इंटरैक्शन का सरल भाषा में अर्थ
Exenatide injectable and Insulin degludec-liraglutide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
ऐसा क्यों होता है
Therapeutic duplication of GLP-1 receptor agonism with additive glucose-lowering effects.
क्या करें
Avoid using two GLP-1 receptor agonists together. Use only one agent and adjust the insulin dose if switching.
फार्मासिस्ट से क्या पूछें
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ सदस्यों के लिए
पूरा पेज खोलें
Exenatide injectable और Insulin degludec-liraglutide की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
वेब पर Pro+ को 14 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।
Insulin degludec-liraglutide के अन्य इंटरैक्शन
अक्सर पूछे जाने वाले प्रश्न
Can I take Exenatide injectable with Insulin degludec-liraglutide?
MediHelp rates the interaction as major. Exenatide injectable and Insulin degludec-liraglutide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Exenatide is a GLP-1 receptor agonist, and the combination product already contains liraglutide, so the two would duplicate therapy. Together they increase gastrointestinal adverse effects and the risk of hypoglycemia without added benefit.
How serious is the interaction between Exenatide injectable and Insulin degludec-liraglutide?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid using two GLP-1 receptor agonists together. Use only one agent and adjust the insulin dose if switching.
What other medicines interact with Insulin degludec-liraglutide?
MediHelp also lists interactions of Insulin degludec-liraglutide with, for example, Albiglutide, Chlorpropamide, Clozapine. The full list is on the Insulin degludec-liraglutide page.
MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर
MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।
